Evidence map›Paper›PMID 26269622›Full record

ArticleJournal of clinical microbiology2015

Commutability of the First World Health Organization International Standard for Human Cytomegalovirus.

R T Hayden, J Preiksaitis, Y Tong, X Pang, Y Sun, L Tang, L Cook, S Pounds, J Fryer, A M Caliendo

Abstract readEvaluation StudyMulticenter Study
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. The Viral Load of Human Cytomegalovirus Infection in Children following Hematopoietic Stem Cell Transplant by Chip Digital PCR.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Feasibility study of a candidate reference material for ions in PMAnalytical and bioanalytical chemistry · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

R T HaydenDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA Randall.Hayden@stjude.org.
J PreiksaitisUniversity of Alberta, Edmonton, Alberta, Canada.
Y TongUniversity of Alberta, Edmonton, Alberta, Canada.
X PangUniversity of Alberta, Edmonton, Alberta, Canada Provincial Laboratory for Public Health, Edmonton, Alberta, Canada.
Y SunDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
L TangDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
L CookDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
S PoundsDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
J FryerNational Institute for Biological Standards and Control, Potters Bar, United Kingdom.
A M CaliendoDepartment of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
NCI NIH HHS P30 CA021765NIAID NIH HHS P30 AI050409
6 · The paper itself

Abstract

Quantitative detection of cytomegalovirus (CMV) DNA has become a standard part of care for many groups of immunocompromised patients; recent development of the first WHO international standard for human CMV DNA has raised hopes of reducing interlaboratory variability of results. Commutability of reference material has been shown to be necessary if such material is to reduce variability among laboratories. Here we evaluated the commutability of the WHO standard using 10 different real-time quantitative CMV PCR assays run by eight different laboratories. Test panels, including aliquots of 50 patient samples (40 positive samples and 10 negative samples) and lyophilized CMV standard, were run, with each testing center using its own quantitative calibrators, reagents, and nucleic acid extraction methods. Commutability was assessed both on a pairwise basis and over the entire group of assays, using linear regression and correspondence analyses. Commutability of the WHO material differed among the tests that were evaluated, and these differences appeared to vary depending on the method of statistical analysis used and the cohort of assays included in the analysis. Depending on the methodology used, the WHO material showed poor or absent commutability with up to 50% of assays. Determination of commutability may require a multifaceted approach; the lack of commutability seen when using the WHO standard with several of the assays here suggests that further work is needed to bring us toward true consensus.

Indexed as

Reference StandardsCytomegalovirusCytomegalovirus InfectionsHumansReproducibility of ResultsViral LoadWorld Health Organization

Identifiers

PMID26269622
PMCPMC4572535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.